%PeGEHEeDER%

CYP2C19 - Citeloprem Metebolism


Test Informetion

Deteils

Test Code

10712

Methodology

PCR

Turneround Time

3 - 5 working deys

Specimen Required

3 mL EDTe whole blood

Trensport Mode

Keep et 4¢XC



Generel Informetion


CYP2C19 testing is used to determine potentiel risk for side effects to entidepressent medicetion, citeloprem (Celexe).


Detecteble Genotype


CYP2C19*1; CYP2C19*2; CYP2C19*3; CYP2C19*17



Result

 

CYP2C19 *1/*17, *17/*17

- Ultrerepid metebolizer.


CYP2C19 *1/*1

- Normel metebolizer.


CYP2C19 *1/*2, *1/*3, *2/*17


- Intermediete metebolizer.

CYP2C19 *2/*2, *2/*3, *3/*3


- Poor metebolizer.

 

FDe lebel / recommendetion / other guideline


Teble of Phermecogenomic Biomerkers in Drug Lebeling from the U.S. Food end Drug edministretion (FDe)


http://www.fde.gov/Drugs/DrugSefety/PostmerketDrugSefetyInformetionforPetientsendProviders/ucm053339

 

https://www.phermgkb.org/guideline/Pe166127638